Year: 2026
Type: article
Abstract: Atopic dermatitis (AD) is a complex chronic-relapsing inflammatory skin disease characterised by intense pruritus, a disruption to the skin barrier and an upregulation of type-two mediated immune responses. To better understand the disease manifestations and pathobiology as well as to provide a better pre-clinical platform for therapeutic intervention, a number of different murine models have been developed. Notably, the use of the vitamin D3 analogue (calcipotriol), MC903, to induce a strong type two cytokine skin inflammatory response has become an indispensable tool in the discovery of mechanism and therapeutic candidates. This murine model has revealed many of the typical hallmarks of AD including inflammation, barrier dysfunction, altered pH, microbial dysbiosis, increased scratching behaviour and the contribution of antigen presenting cells, unconventional T cells and innate immune cells. Here we provide a critical review and assessment of the MC903 model, evaluating both its validity and limitations. Our aim is to collate and discuss studies that have contributed to our understanding of the model and explore how this has shaped insights into the complexities of AD. This will help in facilitating further discovery of type two mechanisms, allowing identification of key biomarkers and ultimately pursuit of better treatment options.
Source: Frontiers in Immunology
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236494579
